Vista Pharmaceuticals Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 5.319 million compared to INR 67.644 million a year ago. Net loss was INR 4.825 million compared to INR 2.122 million a year ago. Basic loss per share from continuing operations was INR 0.13 compared to INR 0.07 a year ago. For the nine months, total revenue was INR 10.242 million compared to INR 252.985 million a year ago. Net loss was INR 15.83 million compared to INR 0.585 million a year ago. Basic loss per share from continuing operations was INR 0.44 compared to INR 0.02 a year ago.